UK Markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.97-0.23 (-1.89%)
At close: 4:00PM EDT
11.97 0.00 (0.00%)
After hours: 05:25PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close12.20
Open12.26
Bid11.93 x 800
Ask11.94 x 1300
Day's range11.92 - 12.36
52-week range11.58 - 29.65
Volume289,475
Avg. volume682,185
Market cap598.998M
Beta (5Y monthly)1.31
PE ratio (TTM)67.63
EPS (TTM)0.18
Earnings date10 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est27.63
  • Could The Cara Therapeutics, Inc. (NASDAQ:CARA) Ownership Structure Tell Us Something Useful?
    Simply Wall St.

    Could The Cara Therapeutics, Inc. (NASDAQ:CARA) Ownership Structure Tell Us Something Useful?

    A look at the shareholders of Cara Therapeutics, Inc. ( NASDAQ:CARA ) can tell us which group is most powerful...

  • Is Cara Therapeutics a Buy for Summer 2021?
    Motley Fool

    Is Cara Therapeutics a Buy for Summer 2021?

    The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.

  • Is Cara Therapeutics a Buy?
    Motley Fool

    Is Cara Therapeutics a Buy?

    With the clinical trial process in the rearview mirror, a lot of the risks associated with development are in the past, leaving "only" the risks of competing profitably. Such is the situation of Cara Therapeutics (NASDAQ: CARA), which is developing a drug called Korsuva to treat pruritus. You've probably experienced pruritus (at least to a small degree) before, because it's the sensation of itchiness.